A Two-arm, Open-label, Single-sequence, Multiple-dose, Cross-over Study to Evaluate the Pharmacokinetic Interaction and the Safety of UIC202502 and UIC202505 in Healthy Adult Volunteers
Latest Information Update: 18 Sep 2025
At a glance
- Drugs UIC 202502 (Primary) ; UIC 202505 (Primary)
- Indications Dyslipidaemias
- Focus Pharmacokinetics
- Sponsors Korea United Pharm Inc
Most Recent Events
- 18 Sep 2025 New trial record